Evidence map›Paper›PMID 27194435›Full record

ArticleJournal of neurovirology2016

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia.

Sam Nightingale, Anna Maria Geretti, Apostolos Beloukas, Martin Fisher, Alan Winston, Laura Else, Mark Nelson, Stephen Taylor, Andrew Ustianowski, Jonathan Ainsworth and 10 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Journal of neurovirology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 1 country.

Sam NightingaleInstitute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK. s.nightingale@liv.ac.uk.
Anna Maria GerettiInstitute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK.
Apostolos BeloukasInstitute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK.
Martin FisherBrighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Alan WinstonSt Marys' Hospital, Imperial College Healthcare NHS Trust, London, UK.
Laura ElseDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Mark NelsonSt Stephen's AIDS Research Trust and Chelsea and Westminster Hospital NHS Foundation Trust, London, UK.
Stephen TaylorBirmingham Heartlands Hospital, Heart of England NHS Foundation Trust, Birmingham, UK.
Andrew UstianowskiNorth Manchester General Hospital, Pennine Acute Hospitals NHS Trust, Manchester, UK.
Jonathan AinsworthNorth Middlesex University Hospital NHS Trust, London, UK.
Richard GilsonResearch Department of Infection and Population Health, University College London, London, UK.
Lewis HaddowResearch Department of Infection and Population Health, University College London, London, UK.
Edmund OngVictoria Royal Infirmary, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK.
Victoria WatsonDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Clifford LeenRoyal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Jane MintonLeeds General Infirmary, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Frank PostKings College Hospital NHS Foundation Trust, London, UK.
Munir PirmohamedDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
Tom SolomonInstitute of Infection and Global Health, University of Liverpool, The Ronald Ross Building, 8 West Derby Street, Liverpool, L69 7BE, UK.
Saye KhooDepartment of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
University of Liverpool · GBUniversity College London · GBChelsea and Westminster Hospital NHS Foundation Trust · GBHeartlands Hospital · GBKing's College Hospital NHS Foundation Trust · GBLeeds Teaching Hospitals NHS Trust · GBNewcastle upon Tyne Hospital · GBNHS Lothian · GBNorth Middlesex University Hospital NHS Trust · GBPennine Acute Hospitals NHS Trust · GBRoyal Liverpool and Broadgreen University Hospital NHS Trust · GBSt. Mary's Hospital · GBUniversity Hospitals Sussex NHS Foundation Trust · GBWalton Centre · GB

Funding

Department of Health IS-HPU-1112-10117Department of Health RP-PG-0108-10048Medical Research Council G1000417
6 · The paper itself

Abstract

The central nervous system has been proposed as a sanctuary site where HIV can escape antiretroviral control and develop drug resistance. HIV-1 RNA can be at higher levels in CSF than plasma, termed CSF/plasma discordance. We aimed to examine whether discordance in CSF is associated with low level viraemia (LLV) in blood. In this MRC-funded multicentre study, we prospectively recruited patients with LLV, defined as one or more episode of unexplained plasma HIV-1 RNA within 12 months, and undertook CSF examination. Separately, we prospectively collected CSF from patients undergoing lumbar puncture for a clinical indication. Patients with durable suppression of viraemia and no evidence of CNS infection were identified as controls from this group. Factors associated with CSF/plasma HIV-1 discordance overall were examined. One hundred fifty-three patients were recruited across 13 sites; 40 with LLV and 113 undergoing clinical lumbar puncture. Seven of the 40 (18 %) patients with LLV had CSF/plasma discordance, which was significantly more than 0/43 (0 %) with durable suppression in blood from the clinical group (p = 0.005). Resistance associated mutations were shown in six CSF samples from discordant patients with LLV (one had insufficient sample for testing), which affected antiretroviral therapy at sampling in five. Overall discordance was present in 20/153 (13 %) and was associated with nadir CD4 but not antiretroviral concentrations in plasma or CSF. CSF/plasma discordance is observed in patients with LLV and is associated with antiretroviral resistance associated mutations in CSF. The implications for clinical practice require further investigation.

Indexed as

AdultAnti-HIV AgentsCD4 Lymphocyte CountCentral Nervous SystemDrug Resistance, ViralFemaleHIV-1HIV InfectionsHumansMaleMiddle AgedNeuropsychological TestsProspective StudiesRNA, ViralViremiaAnti-HIV AgentsRNA, ViralAntiretroviral agentsCentral nervous systemCerebrospinal fluidDrug resistanceHIVViral

Identifiers

PMID27194435
PMCPMC5127885
OpenAlexW2400937230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.